SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-053359
Filing Date
2024-06-17
Accepted
2024-06-17 16:41:10
Documents
14
Period of Report
2024-06-14
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0207966-8k_hoththera.htm   iXBRL 8-K 25973
2 AMENDMENT NO. 2 TO THE AMENDED AND RESTATED BYLAWS OF HOTH THERAPEUTICS, INC ea020796601ex3-1_hoththera.htm EX-3.1 6012
  Complete submission text file 0001213900-24-053359.txt   211062

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE hoth-20240614.xsd EX-101.SCH 3039
4 XBRL LABEL FILE hoth-20240614_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE hoth-20240614_pre.xml EX-101.PRE 22375
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0207966-8k_hoththera_htm.xml XML 3904
Mailing Address 590 MADISON AVENUE 21ST FLOOR NEW YORK NY 10022
Business Address 590 MADISON AVENUE 21ST FLOOR NEW YORK NY 10022 (646)756-2997
Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)

IRS No.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38803 | Film No.: 241048876
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)